National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Tuberculosis
 Understanding TB
 Research
  Research Goals
  Basic Research
  Diagnostic Research
  Advances in Treatment
  Prevention: Vaccine Development
  Global Research
  NIAID Labs
  Networks, Consortia, and Partners
  Services for Researchers
  Research Training
  Meetings
  Scientific Literature
  Feature Stories


Tuberculosis (TB)

Research

The New Challenge for TB Research

NIAID’s Role in Addressing Tuberculosis (TB), Drug-Resistant TB, and TB in People with HIV/AIDS

Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Research Agenda (PDF)

TB Research at NIAID

  • Research Goals
  • Basic Research
  • Diagnostic Research
  • Advances in Treatment
  • Prevention: Vaccine Development
  • Global Research
  • Scientific Illustrations of Drug-Resistant TB
  • NIAID Labs
  • Networks, Consortia and Partners
  • Services for Researchers
  • Training
  • Meetings
  • Scientific Literature
  • Recent Scientific Findings

    Shortening Treatment in Adults with Non-cavitary Tuberculosis and Two-month Culture Conversion

    HIV-1 Infection in Infants Severely Impairs the Immune Response Induced by Bacille Calmette-Guérin Vaccine

    Research Features

    Training Rodents to Sniff Out TB

    Animal Models Speed TB Drug Development

    Engineered Autophagy Boosts Response to BCG Vaccine


    Volunteer for Clinical Studies
    Volunteer for NIAID-funded clinical studies related to tuberculosis on ClinicalTrials.gov.

    See Also

    Global Research, Africa



    Volunteer for Clinical Studies
    Volunteer for NIAID-funded clinical studies related to tuberculosis on ClinicalTrials.gov.

    See Also

    Global Research, Africa